000 | 01678 a2200457 4500 | ||
---|---|---|---|
005 | 20250517062418.0 | ||
264 | 0 | _c20170104 | |
008 | 201701s 0 0 eng d | ||
022 | _a1468-3318 | ||
024 | 7 |
_a10.1136/tobaccocontrol-2015-052375 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeidenberg, Andrew B | |
245 | 0 | 0 |
_aDifferences in the design and sale of e-cigarettes by cigarette manufacturers and non-cigarette manufacturers in the USA. _h[electronic resource] |
260 |
_bTobacco control _cApr 2016 |
||
300 |
_ae3-5 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aCommerce _xeconomics |
650 | 0 | 4 |
_aDirect-to-Consumer Advertising _xeconomics |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 |
_aElectronic Nicotine Delivery Systems _xeconomics |
650 | 0 | 4 | _aEquipment Design |
650 | 0 | 4 |
_aFlavoring Agents _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInternet _xeconomics |
650 | 0 | 4 |
_aManufacturing Industry _xeconomics |
650 | 0 | 4 |
_aNicotine _xadministration & dosage |
650 | 0 | 4 |
_aNicotinic Agonists _xadministration & dosage |
650 | 0 | 4 |
_aSmoking _xadverse effects |
650 | 0 | 4 |
_aSmoking Cessation _xeconomics |
650 | 0 | 4 | _aSmoking Prevention |
650 | 0 | 4 |
_aTobacco Use Disorder _xeconomics |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aVaping _xeconomics |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aJo, Catherine L | |
700 | 1 | _aRibisl, Kurt M | |
773 | 0 |
_tTobacco control _gvol. 25 _gno. e1 _gp. e3-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/tobaccocontrol-2015-052375 _zAvailable from publisher's website |
999 |
_c25427703 _d25427703 |